Supreme Court decision in Loper Bright which overturned decades of precedent deferential to agencies under the Chevron doctrine as authority that the court should interpret parts of the Food Drug & Cosmetic Act regarding shortages without deference to the FDA
Self-switching or overlapping treatments can lead to risks and are not recommended
Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial
Commercial acceptance is expected to depend on dietitian access, escalation rules and maintenance support after early weight loss slows. Strategic Implications Care providers should establish clear points for starting dietitian support and escalating symptoms
Lets Talk About It If youre an HR leader, wellness coordinator, or healthcare provider interested in the real science behind GLP-1 nutritionand how to support employees or patients navigating weight loss medicationsId love to connect
At TrimRx, we believe the key to sustainable success is personalization